ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and NOXA-dependent MCL1 degradation in acute myeloid leukemia cells.

MLA

Chiou, Jing-Ting, and Long-Sen Chang. “ONC212 Enhances YM155 Cytotoxicity by Triggering SLC35F2 Expression and NOXA-Dependent MCL1 Degradation in Acute Myeloid Leukemia Cells.” Biochemical Pharmacology, vol. 224, June 2024, p. 116242. EBSCOhost, https://doi.org/10.1016/j.bcp.2024.116242.

APA

Chiou, J.-T., & Chang, L.-S. (2024). ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and NOXA-dependent MCL1 degradation in acute myeloid leukemia cells. Biochemical Pharmacology, 224, 116242. https://doi.org/10.1016/j.bcp.2024.116242

Chicago

Chiou, Jing-Ting, and Long-Sen Chang. 2024. “ONC212 Enhances YM155 Cytotoxicity by Triggering SLC35F2 Expression and NOXA-Dependent MCL1 Degradation in Acute Myeloid Leukemia Cells.” Biochemical Pharmacology 224 (June): 116242. doi:10.1016/j.bcp.2024.116242.